Business
Update regarding NPXe plc
Update regarding NPXe plc.
About this update from Inspiration Healthcare Group Plc
[{"type":"text","content":"\n \nRNS Number : 2195A Inspiration Healthcare Group PLC 28 May 2019 \n\n28 May 2019\n \nInspiration Healthcare Group plc\n(\"Inspiration Healthcare\", or the \"Company\") \n \nUpdate regarding NPXe plc \n(formerly Neuroprotexeon Limited)\n \nInspiration Healthcare Group plc (AIM:IHC), the global medical technology company notes that further to the statement made on 7 December 2018 regarding the potential IPO of NPXe plc, it has recently been informed that NPXe plc is no longer looking to IPO in the UK but is pursuing a private offering in the USA, which will be conducted under US securities law. \n \nUK Investors remain able to participate in this private offering which is eligible for EIS/VCT relief and should contact NPXe plc directly should they wish to do so. Further announcements will be made should the Company be made aware of material developments. \n \n \nEnquiries:\n \n\n\n\nInspiration Healthcare Group plc\nNeil Campbell, Chief Executive Officer\nMike Briant, Chief Financial Officer\n\n\nTel: 01455 840555\n \n\n\n\n\nNominated Adviser & Broker \nCenkos Securities plc \nMark Connelly\nCameron MacRitchie\n\n\nTel: 0207 397 8900\n \n\n\n\n\nCadogan PR \nAlex Walters\n\n\nTel: 07771 713608\n\n\n\n \nAbout Inspiration Healthcare\n \nInspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. \n \nThrough investment in research and development the Company...